MannKind Corp
MNKD
#6099
Rank
NZ$1.98 B
Marketcap
NZ$6.19
Share price
-1.12%
Change (1 day)
-35.00%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): NZ-$0.12

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is NZ-$0.12. In 2025 the company made an earnings per share (EPS) of NZ$0.03496 a decrease over its 2024 EPS that were of NZ$0.17.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.12-447.4%
2025NZ$0.03496-80%
2024NZ$0.17
2022NZ-$0.596.25%
2021NZ-$0.5628%
2020NZ-$0.44-7.41%
2019NZ-$0.47
2017NZ-$1.94-188.1%
2016NZ$2.20-128.31%
2015NZ-$7.7874.51%
2014NZ-$4.46-20.31%
2013NZ-$5.59-32.63%
2012NZ-$8.30-28.03%
2011NZ-$11.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.29-1,971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
NZ$7.51-6,236.29%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
NZ$49.33-40,421.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.25-5,206.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$5.10-4,271.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$14.72 11,928.57%๐Ÿ‡บ๐Ÿ‡ธ USA